Partnership to advance oesophageal cancer testing - Australian Hospital + Healthcare Bulletin

QIMR Berghofer has signed an agreement with Proteomics allowing the company to develop and commercialise a blood test for early detection of oesophageal cancer.

QIMR Berghofer has signed an exclusive worldwide licence agreement with Proteomics International Laboratories allowing the company to develop and commercialise a blood test for early detection of the… [+2232 chars]

full article...